$0.00
(+0.00%
) Quote detailsUSD
( +0.00%
At Close (As of Jan 1, 1970)
$1.38B
Market Cap
-
P/E Ratio
-0.34
EPS
$5.40
52 Week High
$1.05
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Taysha Gene Therapies, Inc. is a leading gene therapy company based in Dallas, Texas, specializing in the development and commercialization of adeno-associated virus-based therapies aimed at treating monogenic diseases affecting the central nervous system. With a robust pipeline of innovative therapeutics, Taysha is committed to addressing unmet medical needs in the neurology space, leveraging its proprietary gene delivery platform to advance potentially transformative treatment options. The company is poised for growth as it navigates critical clinical development stages and expands collaborations within the biopharmaceutical landscape.